To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

cureTV – Empowering Patients Through Video

Ursula A. Matulonis, M.D.
Chemotherapy and PARP inhibitors may share some side effects, but there are some major differences between the two when it comes to treating ovarian cancer.
Andre Goy, M.D., M.S.
Though it is still being tested in clinical trials, CAR-T cell therapy can offer hope for patients with mantle cell lymphoma whose disease relapsed.
Sagar Lonial, M.D.
Here is what one expert says about the right time to start treating relapsed multiple myeloma.
We spoke to ovarian cancer survivors about their advice for women who are newly diagnosed.
Lori J. Wirth, M.D.
High blood pressure is common in patients with thyroid cancer who are taking Lenvima. Here's what one expert says about managing it.
Alicia Latham Schwark, M.D.
Should cancers that are not traditionally associated with Lynch syndrome or MSI-H status be tested? This expert thinks so.
Audra Moran
Audra Moran, president and CEO of the Ovarian Cancer Research Fund Alliance, discusses the support available for caregivers of women with ovarian cancer.
Saketh Guntupalli, M.D.
Saketh Guntupalli, M.D., gynecologic oncologist at the University of Colorado Hospital, discusses ways that women can improve intimacy after an ovarian cancer diagnosis.
Peter Borchmann, M.D.
CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.
Michael Wang, M.D.
There are many exciting advances happening in the field of mantle cell lymphoma.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable